Effects of Formoterol Inhaled Dry Powder on Exercise Performance in Chronic Obstructive Pulmonary Disease: A Single-Center, Randomized, Double-Blind, Placebo-Controlled, Crossover Study
Open Access
- 1 May 2003
- journal article
- Published by Elsevier in Current Therapeutic Research
- Vol. 64 (5) , 317-326
- https://doi.org/10.1016/s0011-393x(03)00057-2
Abstract
No abstract availableKeywords
This publication has 32 references indexed in Scilit:
- Adrenaline hypothesis: effect of formoterol on noradrenaline releaseJournal of Autonomic Pharmacology, 2001
- Usefulness of the Medical Research Council (MRC) dyspnoea scale as a measure of disability in patients with chronic obstructive pulmonary diseaseThorax, 1999
- Effects of formoterol in apparently poorly reversible chronic obstructive pulmonary diseaseEuropean Respiratory Journal, 1999
- The endurance shuttle walk: a new field test for the assessment of endurance capacity in chronic obstructive pulmonary diseaseThorax, 1999
- FormoterolDrugs, 1998
- A simple method to detect expiratory flow limitation during spontaneous breathingEuropean Respiratory Journal, 1995
- Relation of lung function, maximal inspiratory pressure, dyspnoea, and quality of life with exercise capacity in patients with chronic obstructive pulmonary disease.Thorax, 1994
- Development of a shuttle walking test of disability in patients with chronic airways obstruction.Thorax, 1992
- Quality of life in patients with chronic airflow limitationRespiratory Medicine, 1987
- The Hospital Anxiety and Depression ScaleActa Psychiatrica Scandinavica, 1983